New York, NY (PRWEB) December 19, 2011
Fisher Wallace Laboratories today announced the launch of a new blog dedicated to news and commentary related to Cranial Electrotherapy Stimulation devices (also known as CES devices), Transcranial Magnetic Stimulation (also known as TMS or rTMS) and Electroconvulsive Therapy (also known as ECT):
"Many patients and doctors are still beginning to learn about Cranial Electrotherapy Stimulation, which is a safe, low-cost alternative to Transcranial Magnetic Stimulation," says Charles Fisher, President of Fisher Wallace Laboratories, "This new blog, edited by rising star Susan Chi, will offer a fresh perspective and cutting edge information."
CES devices deliver a gentle electrical current to the brain via electrodes in order to stimulate the production of serotonin, GABA, endorphins and other neurochemicals responsible for improving mood and sleep, and pain suppression. The device has also been shown to lower cortisol (stress hormone). The FDA has cleared Cranial Electrotherapy Stimulation for the treatment of depression, anxiety, insomnia and pain.
Patients typically use the device at home for twenty minutes per treatment session, once or twice a day. You can use the device while reading a book or watching TV. Most patients do not feel the gentle electrical current, while others may feel a slight tingling sensation.
“I have seen very positive results, often within the first two weeks of using the Fisher Wallace Cranial Stimulator,” states Dr. Richard Brown, MD, Associate Clinical Professor of Psychiatry, Columbia Medical Center, “Approximately 75% of my patients who have been diagnosed with generalized anxiety disorder, major depressive disorder, stress related disorders or insomnia have reported positive changes.”
Fisher Wallace Laboratories continues groundbreaking research at Harvard Medical School, Columbia University, Massachusetts General Hospital, NYU Medical Center, University of Maryland, University of Toledo, and McLean Hospital (Harvard Medical School).